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Background: Subjects with normal body mass index (BMI) but elevated amounts of body fat (normal-weight
obesity; NWO) show cardiometabolic dysregulation compared to subjects with normal BMI and normal amounts of
body fat (normal-weight lean; NWL). In this study, we aimed to evaluate whether NWO individuals have higher
rates of subclinical atherosclerosis compared to NWL subjects.
Methods: From a large-scale health checkup system, we identified 2078 normal weight (18.5≤ BMI < 25 kg/m2)
subjects with no previous history of coronary artery disease who underwent analysis of atherosclerosis using coronary
computed tomography angiography (CCTA) and pulse wave velocity (PWV). NWO was defined as normal BMI and
highest tertile of body fat percentage by sex (men ≥25. 4 % and women ≥31.4 %). CCTA was performed using a
64-detector row CT. A plaque was defined as a structure >1 mm2 within and/or adjacent to the vessel lumen and
classified according to the presence/proportion of intraplaque calcification.
Results: NWO subjects (n = 283) demonstrated metabolic dysregulation compared to NWL individuals (n = 1795). After
adjusting for age, sex, and smoking, NWO individuals showed higher PWV values than NWL individuals (1474.0 ± 275.4
vs. 1380.7 ± 234.3 cm/s, p = 0.006 by ANCOVA). Compared with NWL subjects, NWO subjects had a higher prevalence
of soft plaques even after age, sex, and smoking adjustment (21.6 % vs. 14.5 %, p = 0.039 by ANCOVA). The PWV value
and the log{(number of segments with plaque) + 1} showed a positive correlation with numerous parameters such as
age, systolic blood pressure, visceral fat, fasting glucose level, serum triglyceride level, and C-reactive protein (CRP) in
contrast to the negative correlation with high-density lipoprotein-cholesterol level. The visceral fat was an independent
determinant of log{(number of segments with plaque) + 1} (ß = 0.027, SE = 0.011, p = 0.016) even after adjustment for
other significant factors. Most importantly, NWO was an independent risk factor for the presence of soft plaques (odds
ratio 1.460, 95 % confidence interval 1.027–2.074, p = 0.035) even after further adjustment for multiple factors associated
with atherosclerosis (blood pressure, blood glucose, lipid level, CRP, medication, smoking status, physical activity).
Conclusions: NWO individuals carry a higher incidence of subclinical atherosclerosis compared with NWL individuals,
regardless of other clinical risk factors for atherosclerosis.
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Obesity, defined as excess body fat, is a worldwide health
problem and a major risk factor for cardiovascular dis-
ease [1–3]. Body mass index (BMI) has been used as a
parameter of obesity [4]. However, BMI can overestimate
the degree of obesity in people with lower body fat per-
centage and higher lean body mass [5] or underestimate
it in Asians with the opposite body composition [6]. Be-
cause of these limitations in BMI, subjects with so-called
normal-weight obesity (NWO) have been a matter of in-
vestigation recently. Specifically, research has focused on
whether those with higher amounts of body fat even
with normal BMI carry an elevated cardiovascular risk.
In previous studies, NWO subjects have more cardio-
metabolic risk factors [7–10], impaired cardiac function
[11], and are more likely to experience mortality [9]
compared to normal-weight lean (NWL) subjects. Fur-
thermore, our group recently demonstrated using
18fluorodeoxyglucose-positron emission tomography/
computed tomography (18FDG-PET/CT) that NWO
subjects have more subclinical vascular inflammation
[12]. Considering that vascular inflammation is a major
pathologic phenomenon leading to plaque rupture [13, 14],
these findings suggest that NWO subjects may have
more subclinical atherosclerosis, which may in the long-
term lead to significant cardiovascular mortality or mor-
bidity. However, no reports have looked into whether
NWO subjects are really susceptible to atherosclerosis
nor have any in-depth studies investigated the charac-
teristics of atherosclerosis in these patients.
Several methods exist for measuring the degree of ath-
erosclerosis noninvasively. Pulse wave velocity (PWV) is
a marker of vascular stiffness, and many reports have
shown the association between PWV and cardiovascular
events [15]. On the other hand, coronary computed
tomography angiography (CCTA) is most useful for
visualizing the presence or degree of coronary artery
stenosis and is also useful for quantifying plaques and,
more importantly, characterizing plaques [16–18].
In this study, we aimed to analyze whether NWO sub-
jects carry a higher incidence of subclinical atheroscler-
osis than NWL subjects using the above two modalities.
The results provided herein demonstrate that NWO in-
dividuals carry a higher incidence of subclinical athero-
sclerosis compared with NWL individuals, regardless of
other clinical risk factors for atherosclerosis.
Methods
Study design and population
This cross-sectional study included 3546 consecutive sub-
jects who underwent both CCTA and PWV as part of a
self-referred health checkup program at the Gangnam
Severance Hospital Health Promotion Center from July
2006 to February 2014. Among the whole population of3546 subjects, sex-specific tertiles of body fat percentage
(BF%) was calculated according to the absolute value of
body fat percentage measured by bioelectrical impedance
body composition analyzer (BF%, <22.0, 22.0–25.3,
≥25.4 % for men, and <27.3, 27.3–31.3, ≥31.4 % for
women). All patients were divided into three groups ac-
cording to this sex-specific BF% tertiles. Of all subjects,
normal weight (18.5 ≤ BMI < 25 kg/m2) subjects were the
population of interest for the current study (n = 2154).
Among 2154 normal weight subjects, the population who
were in the highest tertile of BF% (BF% ≥25.4 % for men,
and ≥31.4 % for women) was defined as NWO and those
in the lower two tertiles of BF% (BF% <25.4 % for men,
and <31.4 % for women) were defined as NWL. The ex-
clusion criteria of this study were as follows: (1) history of
coronary artery disease, (2) significant hypo/hyperthyroid-
ism (thyroid-stimulating hormone >10 μIU/mL or free
thyroxine >2.0 ng/dL), and (3) significant renal insuffi-
ciency (creatinine >1.5 mg/dL). Ultimately, 2078 subjects
(NWL, n = 1795; NWO, n = 283) were included for ana-
lysis in this study (Fig. 1). The protocol of this study was
approved by the institutional review board of Gangnam
Severance Hospital.
Anthropometric and biochemical measurements
Data on past medical history, concomitant medication
use, smoking, and other medico-social history informa-
tion were collected through a self-administered ques-
tionnaire before the health checkup. The current and
past medical history of disease, medication, smoking sta-
tus (smoker, ex-smoker, non-smoker), alcohol intake
(cup/month), salt intake or regular exercise habitus, and
other information on medico-social history were self-
reported via a routine questionnaire before the health
checkup. The definition of ex-smoker was defined as
those who quitted smoking for at least 1 month before
taking the examination and any subject having a history
of smoking within this period was defined as current
smoker.
Before anthropometric and biochemical examination, all
patients were required to fast for ≥8 h. Height and body
weight were measured, and BMI was calculated as weight in
kilograms divided by the square of height in meters (kg/m2).
Total body fat, visceral fat, subcutaneous fat, and body fat
percentage were measured and estimated using the bioelec-
trical impedance body composition analyzer X-Scan Plus II
(Jawon Medical, Seoul, Korea). Briefly, the tetra-polar elec-
trode method with 8 touch electrodes was used on both
hands and feet, and the bioelectrical impedance value was
evaluated by the current intercrossing between each hand
and foot. By using the waist-to-hip ratio, body weight,
height, age, sex, and the bioelectrical impedance value of the
abdominal area, the Jawon Medical Company created a for-
mula specific for Korean individuals to calculate the visceral
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Fig. 1 Schematic diagram and flow of the registration. CCTA, coronary computed tomography angiography; PWV, pulse wave velocity; BMI, body
mass index; NWL, normal weight lean; NWO, normal weight obesity; BF, body fat; CVD, cardiovascular disease
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excluding the visceral fat from the total fat amount and the
validity of this method has been extensively tested against
CT [12, 19, 20]. Blood pressure (BP) was measured with the
patient in a sitting position after ≥15 min of rest. The pres-
ence of fatty liver presence was assessed using a Philips iU22
Ultrasound System (Philips Healthcare, Andover, MA,
USA). Fasting plasma glucose, total cholesterol, high-density
lipoprotein-cholesterol (HDL-cholesterol), triglyceride, cal-
cium, and C-reactive protein (CRP) levels were measured by
enzymatic methods using a Hitachi 7600–120 automated
chemistry analyzer (Hitachi, Tokyo, Japan). Low-density
lipoprotein-cholesterol (LDL-cholesterol) was calculated
using the Friedewald formula.
Coronary artery calcium score, coronary artery stenosis,
and coronary plaque measurements using multidetector CT
To measure coronary artery calcium scores (CACS) and
coronary artery stenosis and also to characterize intra-
coronary plaques, CCTA was taken using an adequate
multidetector CT scanner (Philips Brilliance 64; Philips
Medical System, Best, The Netherlands). We used a
standard prospective electrocardiogram-gating protocol
with a step-and-shoot technique: 64 × 0.625-mm slice
section collimation, 420-ms rotation time, 120 kV tube
voltage, and 210 mAs tube current. CACS werecalculated with a dedicated software (Extended Bril-
liance Workspace BW V4.5.2.4031, Philips Medical Sys-
tem, Best, The Netherlands) and expressed as Agatston
scores [21].
Based on CACS, the subjects were categorized as having
either no coronary calcium (CACS 0 vs. >0) or severe cor-
onary calcium (CACS ≤100 vs. >100). To localize the seg-
ment with coronary artery stenosis or plaque, all coronary
arteries were categorized as 3 major arteries and 12 small
segments. Significant coronary artery stenosis was defined
as at least one coronary segment with ≥50 % stenosis. A
plaque was defined as a structure >1 mm2 within and/or
adjacent to the vessel lumen and classified according to
the presence/proportion of intraplaque calcification. In
detail, plaques were categorized as calcified (calcium
[>130 Hounsfield units] content ≥50 % of whole plaque),
mixed (calcium content <50 % of whole plaque), and soft
(no calcium content). The number of segments with
plaque was converted to log scale as log{(number of seg-
ments with plaque) + 1}.
Pulse-wave velocity
Brachial-ankle PWV (ba-PWV) was measured using a
volume plethysmographic instrument (VP-1000; Omron
Healthcare Corporation, Kyoto, Japan) [22]. The brachial-
ankle transit time and distance were calculated as the value
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An automatic device recorded electrocardiograms, phono-
cardiograms, and BP at both the brachial artery and the pos-
terior tibial artery. Measurements were performed after the
patient had rested for ≥5 min in the supine position. The
average value of the right and left PWV was used for
analysis.Statistical analyses
Continuous variables with normal distribution were pre-
sented as means ± standard deviation (SD) and those
with skewed distribution such as CACS or number of
coronary segments with any plaque were log trans-
formed for analysis. Categorical variables were presented
as absolute numbers (percentage). Intergroup compari-
sons were performed using Student’s t-test for continu-
ous variables or χ2-test for categorical variables as
appropriate and also performed using analysis of covari-
ance (ANCOVA) after adjusting for age, sex, and smok-
ing as covariates. The sex- and BMI-matched database
was constructed again as necessary by propensity score
matching using SAS and the difference of the parame-
ters between NWL and NWO was analyzed by paired t-
test. The degree of correlation between various cardio-
vascular risk factors and the parameters of subclinical
atherosclerosis, i.e., PWV, coronary artery stenosis, cor-
onary segments with significant stenosis, and coronary
plaque, was expressed as the regression coefficients (ß)
and standard error (SE) after univariate regression ana-
lysis. We performed a multivariate linear regression ana-
lysis to identify independent risk factors for subclinical
atherosclerosis in normal-weight subjects and the results
expressed as ß and SE. Adjusted odds ratios (OR) for the
increase in PWV or the presence of coronary plaque in
the NWO group compared to the NWL group was esti-
mated with logistic regression analysis models. The SPSS
statistical package (version 20.0; SPSS, IBM Corp.,
Armonk, NY, USA) and SAS macro (version 9.2; SAS In-
stitute, Cary, NC, USA) was used for all statistical ana-
lyses. A p-value <0.05 was regarded as statistically
significant.Results
Clinical and biochemical characteristics of the study
population
Clinical and biochemical characteristics of the study subjects
are presented in Table 1. In total, 52.5 % (n= 1795) and
8.3 % (n= 283) of the whole study population (n= 3546)
were categorized as NWL and NWO, respectively, after ex-
cluding the subjects who did not meet the inclusion criteria.
Because NWO subjects were older (p < 0.001) and NWO
were less likely to be males (p < 0.001), and have less
smokers (p= 0.003), we next analyzed all subsequent clinicaland biochemical characteristics after adjusting for age, sex,
and smoking as covariates using ANCOVA.
By ANCOVA, NWO had higher BP (systolic BP, 128.6
± 15.7 vs. 122.5 ± 15.5 mmHg, p < 0.001; diastolic BP,
79.6 ± 9.3 vs. 76.6 ± 10.1 mmHg, p < 0.001). NWO sub-
jects had greater total body fat percentages and more
visceral and subcutaneous fat. In addition, NWO sub-
jects generally displayed an unfavorable metabolic profile
compared with NWL subjects. The prevalence of hyper-
tension and the proportion of individuals taking BP
medications were higher in the NWO group compared
to the NWL group. However, there were no differences
in the prevalence of diabetes or the use of antidiabetic,
lipid-lowering, or antiplatelet agents between the two
groups. Furthermore, there were no differences in nutri-
tional status between the two groups.
Differences in PWV, coronary calcium, and incidence of
intracoronary stenosis/plaque between the NWL and
NWO subjects
Compared to the NWL group, the NWO group had a sig-
nificantly higher mean PWV value even after adjusting with
age, sex, and smoking as covariates (1474.0 ± 275.4 vs.
1380.7 ± 234.3 cm/s, p= 0.006). However, there were no sig-
nificant differences in the prevalence of any coronary cal-
cium (CACS >0; 27.2 % vs. 24.3 %, p= 0.509), severe
coronary calcium (CACS >100; 9.2 % vs. 8.4 %, p= 0.286),
nor mean difference of log (CACS+ 1) (0.43 ± 0.78 vs. 0.39
± 0.77, p= 0.264) between the NWL and NWO groups.
There was no difference in the incidence of significant cor-
onary artery stenosis (>50 % stenosis of any major vessel)
between the two groups (2.1 % vs. 3.9 %, p= 0.075).
Next, we evaluated the prevalence of coronary artery
plaque according to the plaque characteristics. The plaques
were classified as calcified, mixed, or soft as previously de-
fined. The prevalence of any plaque and the log value of the
number of coronary segments with any plaque in the NWO
subjects were not significantly different between the two
groups (45.2 % vs. 35.6 %, p= 0.176 for the prevalence of
any coronary plaque; 0.22 ± 0.26 vs. 0.17 ± 0.25, p= 0.295 for
the log{(number of segments with plaque) + 1}). When the
prevalence of plaque was analyzed according to the plaque
characteristics, NWO subjects had a significantly higher
prevalence of soft plaque (21.6 % vs. 14.5 %, p= 0.039) com-
pared to the NWL subjects. However, there were no differ-
ences in the incidence of calcified or mixed plaques.
Detailed comparisons of the parameters are summarized in
Table 2. We also analyzed the difference of the prevalence of
soft plaque in the sex- and BMI-matched pairs (n = 230 for
each group). The PWV value and the prevalence of soft
plaque were consistently higher in the NWO subjects com-
pared NWL subjects in the matched pairs (PWV, 1484.3 ±
282.4 vs. 1379.5 ± 251.0 cm/s, p < 0.001; soft plaque, 21.7 %
vs. 13.5 %, p= 0.026)
Table 1 Clinical and biochemical characteristics of the study subjects
Entire population n = 2078 NWL n = 1795 NWO n = 283 P-value
Age (yr) 53.4 ± 9.2 52.8 ± 9.2 57.6 ± 8.2 <0.001
Male (n, %) 1141 (54.9) 1026 (57.2) 115 (40.6) <0.001
Smoking status 0.003
Current smoker (n, %) 369 (17.8) 332 (18.5) 37 (13.1)
Ex-smoker (n, %) 557 (29.1) 494 (27.5) 63 (22.3)
Non-smoker (n, %) 1152 (55.4) 969 (54.0) 183 (64.7)
Systolic BP (mmHg) 123.4 ± 15.6 122.5 ± 15.5 128.6 ± 15.7 <0.001
Diastolic BP (mmHg) 77.0 ± 10.1 76.6 ± 10.1 79.6 ± 9.3 <0.001
BMI 22.37 ± 1.7 22.53 ± 4.3 23.9 ± 0.8 <0.001
Body fat percentage (%) 24.4 ± 4.8 23.5 ± 4.3 30.1 ± 3.4 <0.001
Visceral fat (kg) 1.9 ± 0.5 1.75 ± 0.5 2.50 ± 0.4 <0.001
Subcutaneous fat (kg) 12.9 ± 2.5 12.5 ± 2.2 16.0 ± 1.6 <0.001
Fasting glucose (mg/dL) 96.1 ± 17.3 95.7 ± 17.5 99.1 ± 15.9 0.004
Total cholesterol (mg/dL) 193.5 ± 34.8 192.5 ± 34.6 199.6 ± 35.5 0.017
Triglyceride (mg/dL) 107.8 ± 64.9 106.4 ± 65.1 116.6 ± 63.3 <0.001
HDL-cholesterol (mg/dL) 50.8 ± 12.7 51.0 ± 12.8 49.6 ± 11.3 0.002
LDL-cholesterol (mg/dL) 118.0 ± 30.9 117.1 ± 30.6 123.9 ± 32.2 0.002
ALT (IU/L) 22.5 ± 17.35 21.9 ± 17.5 26.4 ± 15.87 <0.001
CRP (mg/L) 1.2 ± 2.0 1.2 ± 2.0 1.6 ± 2.3 0.003
Hypertension (n, %) 697 (33.5) 555 (30.9) 142 (50.2) <0.001
Diabetes mellitus (n, %) 221 (10.6) 184 (10.3) 37 (13.1) 0.656
BP medication (n, %) 409 (19.7) 319 (17.8) 90 (31.8) <0.001
Diabetes medication (n, %) 145 (7.0) 118 (6.6) 27 (9.5) 0.677
Lipid lowering agent (n, %) 214 (10.3) 169 (9.4) 45 (15.9) 0.181
Antiplatelet agent (n, %) 223 (10.7) 186 (10.4) 37 (13.1) 0.971
Fatty liver (n, %) 671 (32.3) 531 (29.6) 140 (49.5) <0.001
Alcohol intake (cup/month) 32.4 ± 11.8 34.0 ± 64.2 22.03 ± 48.4 0.867
Excessive salt intake (n, %) 459 (25.1) 395 (25.0) 64 (25.6) 0.283
Physical activity (n, %) 1432 (73.7) 1245 (74.5) 187 (69.0) 0.049
NWO normal weight obesity, NWL normal weight lean, BP blood pressure, BMI body mass index, HDL-cholesterol high-density lipoprotein cholesterol, LDL-cholesterol
low-density lipoprotein cholesterol, ALT alanine transaminase, CRP C-reactive protein. The difference of age, sex and smoking status between the NWL and the NWO
subjects was analyzed with either Student’s t-test or χ2-test as appropriate. The difference of all other variables was analyzed with analysis of covariance (ANCOVA) using
age, sex, and smoking status as covariates. Continuous variables are presented as mean ± standard deviation. Dichotomous variables are presented as the number of
subjects with the percentage of subjects in the parenthesis
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number of coronary segments with plaque
To analyze the risk factors for elevated PWV and the num-
ber of coronary segments with plaque, we performed uni-
variate and multivariate regression analyses (Table 3). On
univariate analysis, age, systolic and diastolic BP, body fat
percentage, amount of visceral fat, amount of subcutaneous
fat, and fasting glucose, triglyceride, HDL-cholesterol, and
CRP levels were significantly associated with PWV and also
with log{(number of segments with plaque) + 1}. To analyze
the effect of fat on PWV and the number of coronary seg-
ments with plaque, we also performed a multivariate re-
gression analysis with the above significant risk factors.After adjusting for other factors such as age, systolic BP,
and fasting glucose, triglyceride, and CRP levels, the
amount of visceral fat was an independent risk factor for
the number of coronary segments with plaque. However,
none of the factors related to fat (body fat percentage and
amount of visceral fat or subcutaneous fat) were predictive
of PWV after adjusting for other risk factors in a multivari-
ate correlation analysis.
Independent risk factors for subclinical atherosclerosis in
NWO
To determine the actuarial risk of subclinical athero-
sclerosis in NWO subjects compared to NWL subjects,
Table 2 Comparison of various atherosclerosis-associated parameters between the normal weight lean and normal weight obesity
subjects
Entire population n = 2078 NWL n = 1795 NWO n = 283 P-value
PWV, (cm/s) 1393.4 ± 242.4 1380.7 ± 234.3 1474.0 ± 275.4 0.006
CACS
CACS >0 (n, %) 503 (24.7) 427 (24.3) 76 (27.2) 0.509
CACS >100 (n, %) 177 (8.5) 151 (8.4) 26 (9.2) 0.286
Log (CACS +1) 0.40 ± 0.77 0.39 ± 0.77 0.43 ± 0.78 0.264
Coronary artery stenosis (n, %) 76 (3.7) 70 (3.9) 6 (2.1) 0.075
Plaque
Any plaque (%) 767 (36.9) 639 (35.6) 128 (45.2) 0.176
Log{(Number of segments with plaque) + 1} 0.18 ± 0.26 0.17 ± 0.25 0.22 ± 0.26 0.295
Calcified plaque (%) 358 (17.2) 303 (16.9) 55 (19.4) 0.719
Mixed plaque (%) 295 (14.2) 258 (14.4) 37 (13.1) 0.102
Soft plaque (%) 322 (15.5) 261 (14.5) 61 (21.6) 0.039
NWO normal weight obesity, NWL normal weight lean, PWV pulse wave velocity, CACS coronary artery calcium score. Analysis of covariance (ANCOVA) using age,
sex, and smoking status as covariates was used to evaluate the difference of continuous variables and dichotomous variables between NWL and NWO subjects.
Continuous variables are presented as mean ± standard deviation. Dichotomous variables are presented as the number of subjects with the percentage of
subjects in the parenthesis
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to PWV values. The population was also divided into
those with or without coronary plaques and those with
or without soft plaques. The risk of being in the highest
tertile of PWV was 1.394-fold higher in the NWO group
compared to the NWL group after adjusting for age and
sex (adjusted OR 1.394, 95 % confidence interval [CI]
1.043–1.862, p = 0.025). This turned nonsignificant after
further adjusting for systolic BP and fasting glucose,
HDL, and CRP levels. Although the risk of having any
plaque was higher in NWO compared NWL (adjustedTable 3 Degree of correlation between parameters of atheroscleros
parameters
Univariate regression analysis
PWV, mean Log(number of segmen
ß(SE) P-value ß(SE)
Age 14.040 (0.489) <0.001 0.011 (0.001)
Systolic BP 7.968 (0.292) <0.001 0.003 (0.000)
Diastolic BP 10.014 (0.480) <0.001 0.004 (0.001)
Visceral fat 72.374 (10.031) <0.001 0.079 (0.011)
Subcutaneous fat 1.835 (2.146) 0.393 −0.005 (0.002)
Fasting glucose 3.509 (0.297) <0.001 0.003 (0.000)
Total cholesterol −0.046 (0.153) 0.764 0.000 (0.000)
Triglyceride 0.534 (0.081) <0.001 0.000 (0.000)
HDL-cholesterol −2.528 (0.417) <0.001 −0.004 (0.000)
LDL-cholesterol 0.022 (0.173) 0.900 0.000 (0.000)
CRP 15.994 (2.715) <0.001 0.007 (0.003)
PWV pulse-wave velocity, BMI body mass index, BP blood pressure, HDL-cholesterol
cholesterol, CRP C-reactive protein. Univariate and multivariate correlation analysis w
plaque and the various baseline risk factors enlisted above
β, regression coefficient; SE, standard errorOR 1.494, 95 % CI 1.160–1.924, p = 0.002), this also
turned out to be nonsignificant after adjusting for age
and sex. However, the risk of having a soft coronary
plaque in the NWO group was significantly higher than
that in the NWL group, even after adjusting for age and
sex (adjusted OR 1.586, 95 % CI 1.146–2.194, p = 0.005).
This importance of NWO subjects having soft coronary
plaque was persistently significant, even with the addition
of other factors known to influence the development of
atherosclerosis, such as systolic BP, fasting glucose, HDL,
CRP levels, hypertension medication, diabetes medication,is and various underlying anthropometric/biochemical
Multiple regression analysis
ts with plaque + 1) Log{(number of segments with plaque) + 1}
P-value ß(SE) P-value
<0.001 0.010 (0.001) <0.001
<0.001 0.001 (0.000) <0.001
<0.001
<0.001 0.027 (0.011) 0.016
0.021
<0.001 0.001 (0.000) <0.001
0.238
<0.001 0.000 (0.000) 0.016
<0.001
0.526
0.013 0.001 (0.003) 0.795
high-density lipoprotein cholesterol, LDL-cholesterol low-density lipoprotein
as performed between the PWV or the number of coronary segments with
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tus, and physical activity (adjusted OR 1.460, 95 % CI
1.027–2.074, p = 0.035) (Table 4).
Discussion
In this study, the main findings are as follows: (1) NWO
subjects had a higher prevalence of subclinical athero-
sclerosis. More specifically, NWO subjects were more
likely to have soft coronary plaques, independent of
other traditional cardiovascular risk factors. (2) NWO
subjects had higher risk of having higher PWV value,
and also higher risk of the prevalence of having any
plaque. (3) The amount of estimated visceral fat itself
was an independent risk factor for the above parameters
of subclinical atherosclerosis. Altogether, these findings
demonstrate that NWO subjects are more prone to
carry subclinical atherosclerosis, which may evolve into
a significant cardiovascular event in the future.Table 4 Odds ratio of NWO for increased subclinical
atherosclerosis
Odds ratio (95 % CI) P-value
NWL NWO
n = 1795 n = 283
PWV (highest tertile)
Model 1 1.000 (Reference) 2.008 (1.557 - 2.591) <0.001
Model 2 1.394 (1.043 - 1.862) 0.025
Model 3 1.254 (0.927 -1.694) 0.142
Any plaque
Model 1 1.000 (Reference) 1.494 (1.160 - 1.924) 0.002
Model 2 1.271 (0.954 - 1.693) 0.101
Soft plaque
Model 1 1.000 (Reference) 1.615 (1.182 - 2.207) 0.003
Model 2 1.586 (1.146 - 2.194) 0.005
Model 3 1.515 (1.084 - 2.116) 0.015
Model 4 1.539 (1.100 - 2.154) 0.012
Model 5 1.555 (1.110 - 2.177) 0.010
Model 6 1.460 (1.027 - 2.074) 0.035
For PWV, the odds ratio for being in the highest tertile of PMV was analyzed.
For any coronary plaque or soft plaque, the odds ratio for having these
characteristics was analyzed for NWO subjects as compared with the
NWL subjects
Model 1 : before adjustment
Model 2 : adjusted for age and sex
Model 3 : adjusted for age, sex, systolic BP, fasting glucose, HDL, CRP
Model 4: adjusted for age, sex, systolic BP, fasting glucose, HDL, CRP,
anti-hypertension medication, antidiabetic medication, lipid lowering agent,
antiplatelet agent
Model 5: adjusted for age, sex, systolic BP, fasting glucose, HDL, CRP,
anti-hypertension medication, antidiabetic medication, lipid lowering agent,
antiplatelet agent, smoking
Model 6: adjusted for age, sex, systolic BP, fasting glucose, HDL, CRP,
anti-hypertension medication, antidiabetic medication, lipid lowering agent,
antiplatelet agent, smoking, physical activity
CI confidence interval, NWO normal weight obesity, NWL normal weight lean,
PWV pulse wave velocityIncreased prevalence of soft plaque in NWO
Several reports have demonstrated that NWO subjects
are more likely to have more cardiovascular risk factors
than NWL subjects [7–10]. Although these suggest that
these patients are more likely to develop significant fu-
ture cardiovascular events, there has been a gap of data
linking dysregulated cardiometabolic factors and future
cardiovascular events. In this aspect, together with a pre-
vious study of ours [12], this study demonstrates that
NWO subjects do indeed carry a significant degree of
subclinical atherosclerosis. More importantly, we have
demonstrated more direct evidence that NWO itself is
an independent risk factor for having soft plaques, pla-
ques often referred to as “vulnerable” in the literature
[23, 24]. Among various plaques, the soft plaque is a
powerful predictor of significant cardiovascular events
because of its susceptibility to rupture [25]. The fusion
of PET and CCTA have identified increased uptake of
18FDG in the soft plaque of the coronary artery [26],
suggesting a direct link between the characteristics of
the plaque and vascular inflammation. These findings
also demonstrate the usefulness of employing various
imaging tools for identifying those at highest risk for fu-
ture cardiovascular events.
Although previous studies on the NWO population have
consistently shown that NWO patients are indeed “fat,” i.e.,
they have increased amounts of fat in the body, and that
they have elevated systemic inflammatory markers [8, 10,
12, 27], our study showed no significant association between
NWO and PWV, CACS, or coronary stenosis. These find-
ings may imply that the important concept of NWO is in
identifying the patients with increased vascular inflamma-
tion before the progression of vascular stiffness, calcium de-
position, or vascular stenosis. Another explanation would be
that NWO subjects may be more prone to develop future
acute events, as has been shown in a previous report dem-
onstrating that NWO subjects carry a higher risk for cardio-
vascular mortality [9]. As already known, even with the
same “coronary” event, the pathogenesis of stable angina
and acute coronary syndrome is completely different, the
former being the chronic stable occlusion of the coronary
artery by a slowly progressive “stable” plaque causing coron-
ary obstruction and the latter being the acute thrombotic
occlusion by plaque rupture [28–30]. Therefore, being an
NWO subject may be a strong predictor of the latter.
No significant association of PWV, CACS, and advanced
coronary stenosis in NWO
Although we expected an elevation of PWV, CACS, and
advanced coronary stenosis in the NWO subjects, we
could not find a significant association between these pa-
rameters and NWO. PWV is a relatively simple method to
detect the progression of atherosclerosis, and the ESH/
ESC guidelines have also recommended PWV as a reliable
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study, the elevated OR for the higher tertile of PWV after
adjustment for age and sex in NWO subjects was nonsignif-
icant after further adjustment with cardiovascular disease-
related risk factors. This may mean that vascular stiffness
might be more influenced by age and sex than other
fat-related risk factors, at least in normal-weight subjects
[32–34]. On the other hand, this nonsignificant association
between PWV and NWO in our study might be because of
the different method that we used to measure PWV in our
study, ba-PWV and not carotid-femoral PWV [35], and the
different study population.
Coronary calcium scoring is another easy method to de-
tect the progression of coronary atherosclerosis. CACS has
been shown to predict outcome [36] and it is recommended
by the guidelines also that CACS may be reasonable for car-
diovascular risk assessment in patients at intermediate risk
[37]. However, although CACS may be useful for mass
screening, it tells nothing about the composition of the
plaque and the additional value of it over the Framingham
risk score – which is basically a calculation of the future car-
diovascular risk from traditional risk factors – is marginal at
best [36]. In addition, a very low or zero CACS does not
guarantee ‘zero’ future coronary events [38]. The findings of
our study demonstrating that NWO subjects have more soft
plaques on CCTA are therefore notable and again demon-
strates that NWO subjects should be counted as those at a
high risk of future cardiovascular events before the initiation
of coronary calcium deposition.
Stronger association of NWO itself with cardiovascular
disease than BMI
Up to now, reports showing that NWO may be associated
with future vascular events and cardiovascular mortality
have been limited. However, recently, several reports have
started to show that BMI might not be a decent predictor of
the adverse vascular changes compared to waist circumfer-
ence or visceral fat [12, 39, 40]. In addition, metabolically ab-
normal subjects with normal weight seem to exhibit
increased subclinical atherosclerosis or vascular inflamma-
tion compared to metabolically healthy normal weight or
metabolically healthy but obese subjects [41, 42]. In one
study, although there was no significant difference in all-
cause mortality, cardiovascular mortality was increased in
NWO women independent of other cardiovascular disease-
related risk factors [9]. In another study, metabolically obese
normal-weight subjects — subjects with normal weight
but with metabolic dysregulation — also showed higher
all-cause and cardiovascular mortality than metabolically
healthy normal-weight subjects [41, 43]. The results of
those previous papers show that BMI may not be a good
predictor of future cardiovascular disease and that a con-
siderable number of normal-weight subjects may be at risk
of not being treated properly.There are some missing links between the metabolically
unhealthy normal body weight subjects and future cardio-
vascular events. Future large-scale, prospective, long-term
cohort studies are desperately needed to refute whether
these patients are indeed at higher risk for future cardio-
vascular events. It should also be emphasized that some
imaging studies should be complemented as in ours, so as
to provide insights into the missing relationship between
NWO and cardiovascular events. Furthermore, it will also
be important to analyze whether early intervention, either
medically or by aggressive lifestyle modification, in NWO
subjects would lead to a significant reduction in future
events and, if so, who would benefit most by these
measures.
Conclusions
We demonstrated that NWO subjects have a higher sub-
clinical atherosclerosis incidence than NWL subjects, which
was largely driven by the higher prevalence of soft plaques
in the coronary artery, and that the amount of visceral fat is
a major determinant of this subclinical atherosclerosis. A
large-scale prospective cohort study might be warranted to
prove that reduction of elevated amounts of fat in NWO
subjects, by means of diet and/or exercise, will also correct
some of the atherosclerotic risk factors in these patients.
Abbreviations
ALT: Alanine transaminase; BMI: Body mass index; BP: Blood pressure;
CACS: Coronary artery calcium score; CCTA: Coronary computed tomography
angiography; CI: Confidence interval; CRP: C-reactive protein; HDL:
High-density lipoprotein; LDL: Low-density lipoprotein; NWL: Normal-weight
lean; NWO: Normal-weight obesity; OR: Odds ratio; PWV: Pulse wave velocity;
18FDG-PET/CT: 18Fluorodeoxyglucose-positron emission tomography/
computed tomography.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SK (Sohee Kim) contributed to acquisition of data, performed statistical
analysis, drafting of the manuscript. CK, JSP, KHK, CWA, KRK have
contributed to the acquisition of data, interpretation of data and critical
reading of the manuscript. SPL participated in the design of the study,
interpretation of data and critical reading of the manuscript. SK (Shinae
Kang) coordinated the whole study, contributed to the acquisition and
interpretation of data and also, writing of the whole manuscript. All authors
read and approved the final manuscript.
Acknowledgements
We would like to thank the Gangnam Severance Health Promotion
Research Team for supporting the construction of the registry of data from
the Health Promotion Center. We also thank Jung Hwa Hong who works in
Biostatistics Collaboration Unit in Yonsei University College of Medicine.
This study was supported by an unrestricted grant of the Korean Health
Technology R&D Project (HI14C0336), Ministry for Health, Welfare & Family
Affairs, Republic of Korea.
Author details
1Department of Internal Medicine, Gangnam Severance Hospital, Yonsei
University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, Korea.
2Severance Institute for Vascular and Metabolic Research, Yonsei University
College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, Korea.
3Cardiovascular Center and Department of Internal Medicine, Seoul National
Kim et al. Cardiovascular Diabetology  (2015) 14:58 Page 9 of 9University Hospital, 101 Daehak-ro, Jongro-gu, Seoul, Korea. 4Department of
Family Medicine, Health Promotion Center, Gangnam Severance Hospital,
Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul,
Korea.
Received: 12 March 2015 Accepted: 29 April 2015
References
1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the
distribution of body mass index among US adults, 1999–2010. JAMA.
2012;307(5):491–7.
2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in
obesity among US adults, 1999–2000. JAMA. 2002;288(14):1723–7.
3. Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical
practice guidelines for overweight and obesity in Korea. Endocrinol Metab.
2014;29(4):405–9.
4. Weisell RC. Body mass index as an indicator of obesity. Asia Pac J Clin Nutr.
2002;11 Suppl 8:S681–684.
5. Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell
ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in
the adult general population. Int J Obes (Lond). 2008;32(6):959–66.
6. Low S, Chin MC, Ma S, Heng D, Deurenberg-Yap M. Rationale for redefining
obesity in Asians. Ann Acad Med Singapore. 2009;38(1):66–9.
7. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO)
women: an evaluation of a candidate new syndrome. Nutr Metab
Cardiovasc Dis. 2006;16(8):513–23.
8. Marques-Vidal P, Pecoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, et al.
Normal weight obesity: relationship with lipids, glycaemic status, liver
enzymes and inflammation. Nutr Metab Cardiovasc Dis. 2010;20(9):669–75.
9. Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek
J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregula-
tion and cardiovascular mortality. Eur Heart J. 2010;31(6):737–46.
10. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L.
Normal-weight obese syndrome: early inflammation? Am J Clin Nutr.
2007;85(1):40–5.
11. Kosmala W, Jedrzejuk D, Derzhko R, Przewlocka-Kosmala M, Mysiak A,
Bednarek-Tupikowska G. Left ventricular function impairment in patients
with normal-weight obesity: contribution of abdominal fat deposition, profi-
brotic state, reduced insulin sensitivity, and proinflammatory activation. Circ
Cardiovasc Imaging. 2012;5(3):349–56.
12. Kang S, Kyung C, Park JS, Kim S, Lee SP, Kim MK, et al. Subclinical vascular
inflammation in subjects with normal weight obesity and its association
with body fat: an 18F-FDG-PET/CT study. Cardiovasc Diabetol. 2014;13:70.
13. Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–74.
14. Davies MJ. Acute coronary thrombosis–the role of plaque disruption and its
initiation and prevention. Eur Heart J. 1995;16 Suppl L:3–7.
15. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular
events and all-cause mortality with arterial stiffness: a systematic review and
meta-analysis. J Am Coll Cardiol. 2010;55(13):1318–27.
16. Hodgson JM, Reddy KG, Suneja R, Nair RN, Lesnefsky EJ, Sheehan HM.
Intracoronary ultrasound imaging: correlation of plaque morphology with
angiography, clinical syndrome and procedural results in patients
undergoing coronary angioplasty. J Am Coll Cardiol. 1993;21(1):35–44.
17. Assy N, Djibre A, Farah R, Grosovski M, Marmor A. Presence of coronary plaques in
patients with nonalcoholic fatty liver disease. Radiology. 2010;254(2):393–400.
18. Schroeder S, Kopp AF, Baumbach A, Meisner C, Kuettner A, Georg C, et al.
Noninvasive detection and evaluation of atherosclerotic coronary plaques
with multislice computed tomography. J Am Coll Cardiol. 2001;37(5):1430–5.
19. Ryo M, Maeda K, Onda T, Katashima M, Okumiya A, Nishida M, et al. A new
simple method for the measurement of visceral fat accumulation by
bioelectrical impedance. Diabetes Care. 2005;28(2):451–3.
20. Scharfetter H, Schlager T, Stollberger R, Felsberger R, Hutten H, Hinghofer-Szalkay H.
Assessing abdominal fatness with local bioimpedance analysis: basics and
experimental findings. Int J Obes Relat Metab Disord. 2001;25(4):502–11.
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte Jr M, Detrano
R. Quantification of coronary artery calcium using ultrafast computed
tomography. J Am Coll Cardiol. 1990;15(4):827–32.
22. Jung SJ, Park JH, Lee S. Arterial stiffness is inversely associated with a better
running record in a full course marathon race. J Exerc Nutrition Biochem.
2014;18(4):355–9.23. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation.
1995;92(3):657–71.
24. Falk E. Plaque rupture with severe pre-existing stenosis precipitating
coronary thrombosis. Characteristics of coronary atherosclerotic plaques
underlying fatal occlusive thrombi. Br Heart J. 1983;50(2):127–34.
25. O’Holleran LW, Kennelly MM, McClurken M, Johnson JM. Natural history of
asymptomatic carotid plaque. Five year follow-up study. Am J Surg.
1987;154(6):659–62.
26. Alexanderson E, Slomka P, Cheng V, Meave A, Saldana Y, Garcia-Rojas L,
et al. Fusion of positron emission tomography and coronary computed
tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake
in the left main coronary artery soft plaque. J Nucl Cardiol. 2008;15(6):841–3.
27. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular
disease. Circ Res. 2005;96(9):939–49.
28. Davies MJ. The pathophysiology of acute coronary syndromes.
Heart. 2000;83(3):361–6.
29. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage
infiltration in acute coronary syndromes. Implications for plaque rupture.
Circulation. 1994;90(2):775–8.
30. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. Computed
tomographic angiography characteristics of atherosclerotic plaques subsequently
resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54(1):49–57.
31. Hypertension EETFftMoA. 2013 Practice guidelines for the management of
arterial hypertension of the European Society of Hypertension (ESH) and the
European Society of Cardiology (ESC): ESH/ESC Task Force for the
Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925–38.
32. Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: a
critical review of their strengths and weaknesses. J Hypertens.
2003;21(3):463–72.
33. Jani B, Rajkumar C. Ageing and vascular ageing. Postgrad Med J.
2006;82(968):357–62.
34. Im JA, Lee JW, Shim JY, Lee HR, Lee DC. Association between brachial-ankle
pulse wave velocity and cardiovascular risk factors in healthy adolescents.
J Pediatr. 2007;150(3):247–51.
35. Ito N, Ohishi M, Takagi T, Terai M, Shiota A, Hayashi N, et al. Clinical
usefulness and limitations of brachial-ankle pulse wave velocity in the
evaluation of cardiovascular complications in hypertensive patients.
Hypertens Res. 2006;29(12):989–95.
36. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery
calcium score combined with Framingham score for risk prediction in
asymptomatic individuals. JAMA. 2004;291(2):210–5.
37. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. 2010
ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic
adults: a report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol.
2010;56(25):e50–103.
38. Doherty TM, Wong ND, Shavelle RM, Tang W, Detrano RC. Coronary heart
disease deaths and infarctions in people with little or no coronary calcium.
Lancet. 1999;353(9146):41–2.
39. Ren C, Zhang J, Xu Y, Xu B, Sun W, Sun J, et al. Association between carotid
intima-media thickness and index of central fat distribution in middle-aged
and elderly Chinese. Cardiovasc Diabetol. 2014;13:139.
40. Lukich A, Gavish D, Shargorodsky M. Normal weight diabetic patients versus
obese diabetics: relation of overall and abdominal adiposity to vascular
health. Cardiovasc Diabetol. 2014;13:141.
41. Yoo HJ, Hwang SY, Hong HC, Choi HY, Seo JA, Kim SG, et al. Association of
metabolically abnormal but normal weight (MANW) and metabolically
healthy but obese (MHO) individuals with arterial stiffness and carotid
atherosclerosis. Atherosclerosis. 2014;234(1):218–23.
42. Yoo HJ, Kim S, Hwang SY, Hong HC, Choi HY, Seo JA, et al. Vascular inflammation
in metabolically abnormal but normal-weight and metabolically healthy obese
individuals analyzed with (1)(8)F-fluorodeoxyglucose positron emission
tomography. Am J Cardiol. 2015;115(4):523–8.
43. Choi KM, Cho HJ, Choi HY, Yang SJ, Yoo HJ, Seo JA, Kim SG, Baik SH, Choi DS,
Kim NH. Higher Mortality in Metabolically Obese Normal Weight People than
in Metabolically Healthy Obese Subjects in elderly Koreans.
Clinical endocrinology 2013
